Jaguar Health, Inc. has confirmed a reverse stock split of its common stock, set to take effect on November 24, 2026. This strategic move is intended to enhance the company's stock price and improve its market perception. The decision comes after stockholders approved the split during a special meeting held on November 6, 2026.

The reverse stock split will see every 25 shares of the company's common stock automatically reclassified into one share. This change is designed to reduce the number of shares outstanding without altering the total number of authorized shares. As a result, the conversion and exercise prices of stock options and warrants will increase proportionately.

Jaguar Health operates in the pharmaceutical preparations sector, classified under SIC 2834. The company aims to position itself more favorably in the market, which may prompt similar actions from competitors facing stock price challenges.

Background

Jaguar Health, Inc., incorporated in Delaware, focuses on developing and commercializing innovative medicines for animals and humans. The company trades on the Nasdaq under the ticker symbol JAGX. Its recent filings include a 10-Q report and multiple 8-K filings, indicating ongoing corporate activity and financial disclosures.

What the Filing Says

The recent SEC filing outlines the details of the reverse stock split, stating, "every twenty-five (25) shares of the Company’s issued and outstanding Common Stock immediately prior to the Effective Time shall automatically be reclassified into one (1) share of Common Stock." The filing also indicates that no fractional shares will be issued, with stockholders entitled to cash payments instead.

Impact

This reverse stock split will affect all stockholders of Jaguar Health, as their holdings will be consolidated. The company anticipates that this move will enhance its stock price, potentially attracting more investor interest and improving liquidity. Equiniti Trust Company, LLC will act as the exchange agent for the split, ensuring that stockholders receive the appropriate communications regarding their shares.

What's Next

Following the reverse stock split, Jaguar Health will continue trading on the Nasdaq on a Reverse Stock Split-adjusted basis. The filing does not specify any further actions or upcoming votes related to this change.